A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...
News-Medical.Net on MSN9d
Phase 1 trial examines safety and feasibility of stem cell treatment for Parkinson'sA recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem ...
Promising multiple dose PK data continue to support 4-weekly dosing FDA advice received supporting phase 2 design in HS ...
clinical trial design, and trial results (safety assessment, efficacy assessment, and biomarkers). Final Results of the Phase 1 trial were previously disclosed at the Alzheimer’s Association ...
Patients enroll in phase 2 oncology trials seeking access to promising new treatments, but the risk-benefit assessments and ...
Results of IMNN-101 Proof-of-Concept study demonstrate persistent immunogenicity in trial participants and further validate PlaCCine® ...
Results from a phase 1/2 clinical trial of a novel stem cell treatment for cornea injuries found 14 patients treated and tracked for 18 months had a more than 90% success rate at restoring the ...
A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson’s disease in which a patient’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback